Mark E. Saad - Director at Axsome Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
AXSM on Nasdaq
All Insider Reports
All Insider Reports

Mark E. Saad - trading volume in the past year for Axsome Therapeutics, Inc.

Holdings reported by Mark E. Saad for Axsome Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 10,002 $1,652,130 $165.18 31 Dec 2025 Direct
Common Stock 300 $43,566 $145.22 31 Dec 2025 Indirect
Stock Option (Right to Buy) 0 $5,229 $3.50 31 Dec 2025 Direct Common Stock
Restricted Stock Units 1,429 06 Jun 2025 Direct Common Stock

Transactions reported by Mark E. Saad for Axsome Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.